Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

198.61 +2.74 (+1.40%)
Official Closing Price Updated: 4:10 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
From AINewsWire
Via GlobeNewswire
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron... 
Via StockStory
News headline image
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a... 
Via Finterra
Topics Artificial Intelligence Retirement World Trade
News headline image
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
Although the S&P 500 is down 2.8% over the past six months, Danaher’s stock price has fallen further to $190.75, losing shareholders 9.3% of their capital. T... 
Via StockStory
Topics Stocks
News headline image
The Often-Missed Corner of Healthcare That Wall Street Is Loving ↗
Via MarketBeat
News headline image
Spotting Winners: Danaher (NYSE:DHR) And Research Tools & Consumables Stocks In Q4
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Danaher (NYSE:DHR) and its peers. Th... 
Via StockStory
Topics Economy
News headline image
1 S&P 500 Stock Worth Your Attention and 2 Facing Headwinds
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal
As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
1 Profitable Stock to Target This Week and 2 We Avoid
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Masimo Corporation (Nasdaq – MASI), IHS Holding Limited (NYSE – HIS), VerifyMe, Inc. (Nasdaq – VRME), Great Lakes Dredge & Dock Corporation (Nasdaq – GLDD)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026
WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the... 
Via MarketMinute
Topics Earnings Economy World Trade
News headline image
The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗
As AI uncertainty weighs on stocks, consider loading up on these dividend-growth blue chips instead. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire... 
Via MarketMinute
News headline image
Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring
In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Naya Capital Adds Masimo Shares ↗
Masimo supplies noninvasive monitoring tech to hospitals and care providers, serving both medical and consumer health markets worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
Billionaire Investors Warren Buffett, Bill Ackman and Other Have Been Buying These Stocks ↗
Every quarter, we get to see what the best of the best have bought and sold. 
Via The Motley Fool
News headline image
Danaher's $9.9 Billion Bet: Masimo Acquisition to Redefine the Diagnostics Landscape
In a move that signals a massive consolidation in the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot
As of February 17, 2026, Danaher Corporation (NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington,... 
Via Finterra
Topics Artificial Intelligence Earnings Supply Chain
Discover the top S&P500 movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Danaher Deal Finalized: Company To Acquire Masimo For $9.9 Billion In Cash ↗
The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization. 
Via Stocktwits
News headline image
Masimo to be Acquired by Danaher for $180.00 Per Share
From Masimo Corporation
Via Business Wire
News headline image
Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple ↗
Danaher is reportedly set to acquire Masimo, with the deal expected to be announced as early as Tuesday. 
Via Stocktwits
Topics Intellectual Property
News headline image
Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Water Powerhouse at a Crossroads: A Deep Dive into Xylem Inc (XYL) in 2026
On February 11, 2026, the global water technology leader Xylem Inc (NYSE: XYL) finds itself at a critical crossroads. Following the release of its full-year 2025 earnings report just yesterday, the... 
Via Finterra
Topics Artificial Intelligence Intellectual Property
News headline image
The Measurement Giant Reimagined: A Deep Dive into Waters Corporation (WAT) in 2026
As of February 10, 2026, Waters Corporation (NYSE: WAT) stands at the most significant crossroads in its nearly 70-year history. Long regarded as the gold standard in liquid chromatography and mass... 
Via Finterra
Topics Economy
News headline image
The Evolution of a Compounder: A Deep-Dive Into Fortive Corp (FTV)
As of February 5, 2026, Fortive Corp (NYSE: FTV) finds itself at a pivotal crossroads. Long known as the "industrial-tech compounder" born from the Danaher heritage, the company has recently completed... 
Via Finterra
Topics Artificial Intelligence Earnings Electric Vehicles
News headline image
Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation
Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.